Correction: An earlier version of this story incorrectly characterized the portion of last quarter's loss that was due to ...

The U.S. Department of Justice filed a lawsuit on Friday accusing Walgreens of filling millions of unlawful opioid prescriptions. The civil suit filed in the U.S. District Court for the Northern ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) fell sharply last year as a combination of declining vaccine demand, ...

The U.S. Department of Justice this week filed a lawsuit against Walgreens, alleging the company knowingly filled illegal prescriptions with no medical purpose, including opioids. Walgreens is ...

Walgreens has recently cut its dividend by 48%, from $0.48 per share in Q4 2023 to $0.25 in Q1 2024. The reason given by CEO Tim Wentworth was to prioritize capital allocation. Considering Walgreens' ...

Walgreens Boots Alliance surged by >25% today, following strong Q1 2025 earnings and revenue outperformance. Click here to ...

Walgreens also ended up recording a $5.8 billion impairment charge related to its VillageMD investment in fiscal 2024. Walgreens tried to sell its international chain – Boots – but decided not ...

Locking up store merchandise can deter shoplifters and paying customers alike, according to Walgreens. The pharmacy chain's CEO Tim Wentworth said in Walgreens Boots Alliance's first-quarter ...

In March, CEO Tim Wentworth said Walgreens had recorded a $5.8 billion impairment charge related to VillageMD, and that VillageMD would close 160 clinics. In August, Walgreens said in a filing ...

In the second-quarter report, out at the end of March, Walgreens dropped another bomb on investors, taking a $5.8 billion goodwill impairment on VillageMD. It acquired the primary care and urgent ...